These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Ventricular dysrhythmias following an alfentanil anesthetic in a patient on reserpine for hypertension. Jahr JS; Weber S Acta Anaesthesiol Scand; 1991 Nov; 35(8):788-9. PubMed ID: 1722376 [TBL] [Abstract][Full Text] [Related]
90. Naloxone dosage for opioid reversal: current evidence and clinical implications. Rzasa Lynn R; Galinkin JL Ther Adv Drug Saf; 2018 Jan; 9(1):63-88. PubMed ID: 29318006 [TBL] [Abstract][Full Text] [Related]
91. Ventricular Tachycardia After Naloxone Administration: a Drug Related Complication? Case Report and Literature Review. Lameijer H; Azizi N; Ligtenberg JJ; Ter Maaten JC Drug Saf Case Rep; 2014 Dec; 1(1):2. PubMed ID: 27747471 [TBL] [Abstract][Full Text] [Related]
92. Naloxone in opioid poisoning: walking the tightrope. Clarke SF; Dargan PI; Jones AL Emerg Med J; 2005 Sep; 22(9):612-6. PubMed ID: 16113176 [TBL] [Abstract][Full Text] [Related]
93. The cardiovascular effects of naloxone administration after fentanyl anesthesia in hypercapnic patients. Kishikawa K; Namiki A; Iwasaki H J Anesth; 1989 Mar; 3(1):48-53. PubMed ID: 15236056 [TBL] [Abstract][Full Text] [Related]
94. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Wagner BK; O'Hara DA Clin Pharmacokinet; 1997 Dec; 33(6):426-53. PubMed ID: 9435992 [TBL] [Abstract][Full Text] [Related]
95. Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans. Oldroyd KG; Rankin AC; Gray CE; Harvey K; Borland W; Rae AP; Cobbe SM Br J Clin Pharmacol; 1994 Mar; 37(3):289-94. PubMed ID: 8198939 [TBL] [Abstract][Full Text] [Related]
96. Reversal agents in sedation and anesthesia: a review. Anderson JA Anesth Prog; 1988; 35(2):43-7. PubMed ID: 3137841 [TBL] [Abstract][Full Text] [Related]
97. Use of naloxone in septic shock. Canady J; Williams W; Thompson I; Vincent GS; Hoover E J Natl Med Assoc; 1989 Jun; 81(6):669-73. PubMed ID: 2746688 [TBL] [Abstract][Full Text] [Related]
98. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine. Mills CA; Flacke JW; Flacke WE; Bloor BC; Liu MD Can J Anaesth; 1990 Mar; 37(2):238-44. PubMed ID: 2311152 [TBL] [Abstract][Full Text] [Related]
100. Ventricular irritability associated with the use of naloxone hydrochloride. Two case reports and laboratory assessment of the effect of the drug on cardiac excitability. Michaelis LL; Hickey PR; Clark TA; Dixon WM Ann Thorac Surg; 1974 Dec; 18(6):608-14. PubMed ID: 4139935 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]